BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37097694)

  • 1. Helical Tomotherapy of Lymph Node-negative Early-stage Breast Cancer After Breast-conserving Surgery: Long-term Results.
    Zwicker F; Klepper R; Hauswald H; Hoefel S; Raether L; Huber PE; Debus J; Schempp M
    Anticancer Res; 2023 May; 43(5):2041-2053. PubMed ID: 37097694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.
    Meng J; Huang W; Mei X; Yu X; Pan Z; Ma J; Ma X; Chen J; Guo X; Yang Z
    Strahlenther Onkol; 2020 Sep; 196(9):764-770. PubMed ID: 32318767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
    Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
    Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Helical Tomotherapy and Direct Tomotherapy in Bilateral Whole Breast Irradiation in a Case of Bilateral Synchronous Grade 1 and Stage 1 Breast Cancer.
    Lancellotta V; Iacco M; Perrucci E; Zucchetti C; Dipilato AC; Falcinelli L; Palumbo I; Aristei C
    Am J Case Rep; 2017 Sep; 18():1020-1023. PubMed ID: 28935854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer.
    Lee HH; Chen CH; Luo KH; Chuang HY; Huang CJ; Cheng YK; Chen F; Kuo SH; Huang MY
    Sci Rep; 2020 Mar; 10(1):4342. PubMed ID: 32152428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
    Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
    Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
    Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series.
    Franco P; Zeverino M; Migliaccio F; Sciacero P; Cante D; Casanova Borca V; Torielli P; Arrichiello C; Girelli G; Numico G; La Porta MR; Tofani S; Ricardi U
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1927-36. PubMed ID: 24037488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
    Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis.
    Stoian R; Erbes T; Zamboglou C; Scholber J; Gainey M; Sachpazidis I; Haehl E; Spohn SKB; Verma V; Krug D; Rühle A; Juhasz-Böss I; Grosu AL; Nicolay NH; Sprave T
    Strahlenther Onkol; 2021 Sep; 197(9):812-819. PubMed ID: 33938966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
    Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: Single centre experience.
    Zolcsak Z; Loap P; Fourquet A; Kirova YM
    Cancer Radiother; 2022 Sep; 26(5):654-662. PubMed ID: 35227593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
    Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
    Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
    Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy.
    Yang JF; Lee MS; Lin CS; Chao HL; Chen CM; Lo CH; Fan CY; Tsao CC; Huang WY
    Medicine (Baltimore); 2016 Mar; 95(11):e3113. PubMed ID: 26986158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.